neoadjuvant SCRT followed by Sintilimab plus CAPOX
Sponsors
Sun Yat-sen University
Conditions
Rectal Cancer
Phase 2
A Clinical Study Based on FAPI-PET/CT Technology to Predict Pathological Complete Response After Neoadjuvant Chemoradiotherapy for MSS Rectal Cancer
CompletedNCT06608537
Start: 2024-12-01End: 2025-12-30Updated: 2026-03-04
Neoadjuvant Chemoradiotherapy Plus Sintilimab for MSS, Locally Advanced Rectal Cancer-
WithdrawnNCT06895577
Start: 2025-06-20End: 2025-12-31Updated: 2025-05-21